MARLYN NEWBY: Open Payments
NPI 1629091731 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,109 in 33 payments from 10 companies in 2025. Trend: 2023 $2,092 · 2024 $2,473 · 2025 $2,109
Food & beverage: $2,097Education: $12
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $367 |
| AstraZeneca Pharmaceuticals LP | 5 | $353 |
| Novo Nordisk Inc | 6 | $300 |
| Lilly USA, LLC | 7 | $256 |
| Amgen Inc. | 2 | $244 |
| Insulet Corporation | 2 | $243 |
| Otsuka America Pharmaceutical, Inc. | 2 | $144 |
| Phathom Pharmaceuticals, Inc. | 1 | $101 |
| Exact Sciences Corporation | 3 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
Products named: EVENITY, OMNIPOD, AREXVY, AIRSUPRA, REXULTI, Wegovy, Ozempic, BREZTRI.
Industry payments across NM — which companies pay providers there.
